History Says Micron Stock Gains 28% During the Fourth Quarter. Here's Why I Think Shares Will Surge Even More Before 2026 Is Over.

Micron shares are down roughly 17% from their September close through Oct. 16, but the article argues that tight AI-driven memory supply and a $35.16 billion repurchase authorization could support a recovery. Fiscal 2027 earnings estimates of about $176 per share against a roughly $911 share price imply a forward P/E of approximately 5.2; Micron plans to increase capital returns beginning Dec. 9, subject to CHIPS Act funding restrictions. The outlook is tempered by memory-industry cyclicality and rising competition from China's CXMT.

Analysis

The key transmission is not simply AI capex, but whether memory remains the binding constraint and suppliers can convert scarcity into durable pricing without accelerating supply or inviting substitution. MU benefits if HBM/DRAM pricing and mix improve; customers such as MSFT, AMZN, GOOG, META, and NVDA may face higher system costs, while Apple could pass some memory inflation through but risk demand elasticity. These are conditional effects, not established earnings outcomes.

Near term, customer earnings are catalysts only if they confirm sustained deployments and supply tightness; headline capex alone does not establish MU’s realized pricing, yields, or margins. The buyback authorization is not equivalent to cash deployed: actual repurchases depend on cash generation and CHIPS-related restrictions. The quoted low forward multiple is also vulnerable to peak-cycle earnings estimates and should not be treated as a normalized valuation.

Over 1–3 months, watch MU guidance, HBM shipment/yield commentary, contract pricing, and hyperscaler capex revisions. Over 6–18 months, the main downside is supply catching up, weaker AI spending, or memory price declines; CXMT adds a longer-run competitive risk, though timing and product substitutability require verification. A bullish thesis weakens materially if MU lowers pricing/margin expectations or customers trim deployment plans. Seasonal returns are not a catalyst by themselves.

Key Decisions for Investors

• Consider a staged long in MU rather than buying the full position ahead of customer earnings: initiate only a starter exposure, then add if MU and major customers confirm tight HBM/DRAM supply, firm pricing, and sustained AI investment.
• Treat the repurchase authorization as optional support, not a near-term EPS forecast. Verify actual repurchase pace, cash generation, and the CHIPS Act restrictions before assigning it material value.
• Use MU’s next guidance and subsequent pricing/supply commentary as thesis tests. Reduce or exit if margins or pricing expectations are cut, or if hyperscalers signal a material capex slowdown; avoid anchoring on the article’s FY2027 EPS multiple without testing cycle-normalized earnings.